- Home
- TCX vs LYEL Comparison
TCX vs LYEL Comparison
Compare TCX & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCX
- LYEL
- Stock Information
- Founded
- TCX 1992
- LYEL 2018
- Country
- TCX Canada
- LYEL United States
- Employees
- TCX N/A
- LYEL N/A
- Industry
- TCX EDP Services
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- TCX Technology
- LYEL Health Care
- Exchange
- TCX Nasdaq
- LYEL Nasdaq
- Market Cap
- TCX 215.1M
- LYEL 207.7M
- IPO Year
- TCX 1996
- LYEL 2021
- Fundamental
- Price
- TCX $17.00
- LYEL $0.40
- Analyst Decision
- TCX
- LYEL Sell
- Analyst Count
- TCX 0
- LYEL 2
- Target Price
- TCX N/A
- LYEL $1.00
- AVG Volume (30 Days)
- TCX 21.7K
- LYEL 702.4K
- Earning Date
- TCX 05-08-2025
- LYEL 05-20-2025
- Dividend Yield
- TCX N/A
- LYEL N/A
- EPS Growth
- TCX N/A
- LYEL N/A
- EPS
- TCX N/A
- LYEL N/A
- Revenue
- TCX $369,427,000.00
- LYEL $61,000.00
- Revenue This Year
- TCX N/A
- LYEL N/A
- Revenue Next Year
- TCX N/A
- LYEL N/A
- P/E Ratio
- TCX N/A
- LYEL N/A
- Revenue Growth
- TCX 6.66
- LYEL N/A
- 52 Week Low
- TCX $13.27
- LYEL $0.39
- 52 Week High
- TCX $26.48
- LYEL $2.88
- Technical
- Relative Strength Index (RSI)
- TCX 54.72
- LYEL 37.66
- Support Level
- TCX $16.25
- LYEL $0.41
- Resistance Level
- TCX $17.08
- LYEL $0.51
- Average True Range (ATR)
- TCX 0.64
- LYEL 0.05
- MACD
- TCX 0.15
- LYEL 0.00
- Stochastic Oscillator
- TCX 58.29
- LYEL 8.33
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.